Clinical Trials Logo

Filter by:
NCT ID: NCT05166525 Completed - Heart Failure Clinical Trials

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk

KP NOURISH
Start date: April 27, 2020
Phase: N/A
Study type: Interventional

This study is a virtual, remote, decentralized pragmatic clinical trial comparing the efficacy of medically tailored meals alone or medically tailored meals with remote nutritional counseling compared with usual standard of care in adults with a targeted, nutrition-sensitive chronic medical condition (heart failure, diabetes mellitus, chronic kidney disease).

NCT ID: NCT05166512 Completed - Pre-diabetes Clinical Trials

Pilot Trial of a Novel Cooking Skills Intervention (DPPCooks) to Prevent Diabetes

DPPCooks
Start date: February 2, 2022
Phase: N/A
Study type: Interventional

In this pilot trial participants will be randomized 1:1 to participate in either standard Diabetes Prevention Program (DPP) vs. DPP plus a novel cooking skills intervention (DPP Cooks). The researchers hypothesize that participants randomized to DPP Cooks will have greater weight loss, better diet quality at 4 months, and greater confidence in their cooking skills and ability to implement dietary changes recommended in the DPP.

NCT ID: NCT05166421 Completed - Clinical trials for Corona Virus Disease

Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants

Start date: November 30, 2021
Phase: Phase 1
Study type: Interventional

The study will assess pharmacokinetic (PK) comparability between different formulations of AZD7442, which is a combination of two individual monoclonal antibodies (mAbs), AZD8895 and AZD1061.

NCT ID: NCT05166200 Completed - Glycemic Control Clinical Trials

Glycemic Response in Adults With Type 2 Diabetes

Start date: March 11, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled, crossover study to compare the effects of two treatments on postprandial glucose in adults with type 2 diabetes.

NCT ID: NCT05166187 Completed - Clinical trials for Peripheral Artery Disease

Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease

Start date: April 20, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to understand how a Best Practice Advisory (BPA) for high-intensity statin therapy in patients with Peripheral Artery Disease impacts prescription rates.

NCT ID: NCT05166096 Completed - Healthy Clinical Trials

Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects

Start date: December 3, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.

NCT ID: NCT05165693 Completed - Glycemic Control Clinical Trials

Evaluation of Glycemic Response in Individuals With Type 2 Diabetes

Start date: February 23, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled, crossover study to compare the effects to two treatments on postprandial glucose in adults with type 2 diabetes.

NCT ID: NCT05165550 Completed - HIV-1-infection Clinical Trials

Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects

Start date: April 12, 2022
Phase: Phase 1
Study type: Interventional

To assess the safety and tolerability of Elsulfavirine following administration of single oral ascending doses in HIV-negative, healthy subjects.

NCT ID: NCT05165485 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Phase 4 COPD and Suboptimal Inspiratory Flow Rate

PIFR-2
Start date: January 7, 2022
Phase: Phase 4
Study type: Interventional

Study is a randomized, double-blind, double-dummy, parallel-group study evaluating efficacy and safety of revefenacin vs. tiotropium in adults with severe to very severe COPD and suboptimal PIFR.

NCT ID: NCT05165394 Completed - Clinical trials for Major Depressive Disorder

Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD

TERPSIS
Start date: November 30, 2021
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of NBI-1065846 compared with placebo on improving symptoms of anhedonia in participants with major depressive disorder (MDD).